Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terumi Higuchi

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Endocrine Journal|September 17, 2011
The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysisMidori Ito, Masanori Abe, Kazuyoshi Okada, et al.
Kidney & Blood Pressure Research|January 29, 2005
Prolonged protective effect of short daily hemodialysis against dialysis-induced hypotensionKazuyoshi Okada, Masanori Abe, Chihiro Hagi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 29, 2015
Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled TrialTerumi Higuchi, Masanori Abe, Toshio Yamazaki, et al.
Sleep Medicine|June 14, 2015
Association of restless legs syndrome with oxidative stress and inflammation in patients undergoing hemodialysisTerumi Higuchi, Masanori Abe, Mari Mizuno, et al.
Diabetes Research and Clinical Practice|June 21, 2016
Efficacy and safety of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in hemodialysis patients with diabetic nephropathy: A randomized open-label prospective trialMasanori Abe, Terumi Higuchi, Masari Moriuchi, et al.
Expert Opinion on Pharmacotherapy|January 8, 2013
The dipeptidyl peptidase-4 inhibitor alogliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysisYuki Fujii, Masanori Abe, Terumi Higuchi, et al.
Nutrients|November 7, 2019
Prevalence of Carnitine Deficiency and Decreased Carnitine Levels in Patients on Peritoneal DialysisSatoshi Shimizu, Hiroyuki Takashima, Ritsukou Tei, et al.
Internal Medicine (Tokyo, Japan)|April 6, 2006
Correction of copper deficiency improves erythropoietin unresponsiveness in hemodialysis patients with anemiaTerumi Higuchi, Yoshihiro Matsukawa, Kazuyoshi Okada, et al.
Nutrients|December 24, 2014
Effects of levocarnitine on brachial-ankle pulse wave velocity in hemodialysis patients: a randomized controlled trialTerumi Higuchi, Masanori Abe, Toshio Yamazaki, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 17, 2004
The salvage of graft occlusion in a maintenace hemodialysis patient with tuberous sclerosis by percutaneous transluminal angioplasty using intravascular ultrasound: case reportTerumi Higuchi, Masanori Abe, Kazuyoshi Okada, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Endocrine Journal|September 17, 2011
The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysisMidori Ito, Masanori Abe, Kazuyoshi Okada, et al.
Kidney & Blood Pressure Research|January 29, 2005
Prolonged protective effect of short daily hemodialysis against dialysis-induced hypotensionKazuyoshi Okada, Masanori Abe, Chihiro Hagi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 29, 2015
Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled TrialTerumi Higuchi, Masanori Abe, Toshio Yamazaki, et al.
Sleep Medicine|June 14, 2015
Association of restless legs syndrome with oxidative stress and inflammation in patients undergoing hemodialysisTerumi Higuchi, Masanori Abe, Mari Mizuno, et al.
Diabetes Research and Clinical Practice|June 21, 2016
Efficacy and safety of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in hemodialysis patients with diabetic nephropathy: A randomized open-label prospective trialMasanori Abe, Terumi Higuchi, Masari Moriuchi, et al.
Expert Opinion on Pharmacotherapy|January 8, 2013
The dipeptidyl peptidase-4 inhibitor alogliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysisYuki Fujii, Masanori Abe, Terumi Higuchi, et al.
Nutrients|November 7, 2019
Prevalence of Carnitine Deficiency and Decreased Carnitine Levels in Patients on Peritoneal DialysisSatoshi Shimizu, Hiroyuki Takashima, Ritsukou Tei, et al.
Internal Medicine (Tokyo, Japan)|April 6, 2006
Correction of copper deficiency improves erythropoietin unresponsiveness in hemodialysis patients with anemiaTerumi Higuchi, Yoshihiro Matsukawa, Kazuyoshi Okada, et al.
Nutrients|December 24, 2014
Effects of levocarnitine on brachial-ankle pulse wave velocity in hemodialysis patients: a randomized controlled trialTerumi Higuchi, Masanori Abe, Toshio Yamazaki, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 17, 2004
The salvage of graft occlusion in a maintenace hemodialysis patient with tuberous sclerosis by percutaneous transluminal angioplasty using intravascular ultrasound: case reportTerumi Higuchi, Masanori Abe, Kazuyoshi Okada, et al.
Pageof 3